Constellation Brands is trading at $140.25, down 0.84% on October 14, 2025, continuing its decline from the October 13, 2025 close of $141.44. The stock is moving in line with broader market weakness, as the S&P 500 is down 0.51% amid subdued trading following Friday's sharp selloff. Recent company developments include Q3 2025 results reported around October 12, 2025, which beat analysts' revenue and EPS expectations despite a 15% year-over-year revenue decline to $2.48 billion, with non-GAAP earnings of $3.63 per share exceeding estimates by 6.5%. However, full-year organic revenue and EPS guidance was lowered, though the stock initially traded up 3.8% to $144.01 immediately after reporting. The company faced unusual expenses of $443 million that detracted from earnings, but analysts view this as a one-off factor that could support improved results going forward. Additionally, Warren Buffett's Berkshire Hathaway initiated a position in Constellation Brands in Q4 2024 and continued buying in 2025, viewing the stock's pullback due to consumer weakness in alcoholic beverages as an opportunity to acquire quality brands like Corona and Modelo at a discount.